Financial PerformanceSLRC reported NOI of $0.45, above the $0.43 estimate, on higher asset yields likely stemming from repayments in its Life Science portfolio.
Investment StrategyManagement sees 'compelling investments' and, with low leverage, views SLRC as being 'positioned very favorably' to take advantage of growth opportunities.
Portfolio QualitySLRC's investment portfolio has many favorable attributes: 1) high quality, 2) first lien, and 3) floating rate.